Effectiveness, Stability and Influence Factors of Femtosecond Laser Assisted Cataract Surgery
1 other identifier
observational
105
1 country
1
Brief Summary
What is this study about? This study looks at whether a laser procedure called femtosecond laser-assisted arcuate keratotomy (FSAK) helps people with both cataracts and mild astigmatism see more clearly after cataract surgery. Astigmatism causes blurry vision because the front of the eye (cornea) is curved unevenly. The FSAK procedure uses a computer-guided laser to make tiny, precise cuts in the cornea during cataract surgery to fix this curve. the investigators want to see if this improves vision long-term (up to 5 years) and what factors affect how the investigatorsll it works. Who can join? the investigators are looking for adults aged 20-80 years who: Have cataracts and mild-to-moderate astigmatism (0.75-2.0 diopters) Plan to have cataract surgery Have not had prior eye surgeries (like LASIK) Do not have severe dry eye or other eye diseases (like glaucoma or retina problems) What will happen in the study? Surgery: Participants will have cataract surgery combined with the FSAK procedure. The surgeon uses a laser to make tiny curved cuts in the cornea to reshape it. Follow-up visits: Participants will have regular eye check-ups for 5 years after surgery. These include: Vision tests (reading eye charts) Measurements of the eye's shape using painless imaging machines Questionnaires about vision quality and daily activities Time commitment: Visits happen at 1 the investigatorsek, 1 month, 3 months, 6 months, 1 year, 2 years, and 5 years after surgery. Each visit takes about 1-2 hours. Why is this study important? FSAK may help people with astigmatism see clearly after cataract surgery without needing glasses as often. By tracking results for 5 years, the investigators'll learn how long the benefits last and who benefits most. This could help doctors better personalize treatment in the future. Who is running the study? Eye doctors at Fudan University Eye \& ENT Hospital (Shanghai) and Shanghai Peace Eye Hospital. About 105 people will take part.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 22, 2025
CompletedFirst Submitted
Initial submission to the registry
June 1, 2025
CompletedFirst Posted
Study publicly available on registry
July 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 22, 2031
July 23, 2025
July 1, 2025
5 years
June 1, 2025
July 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in corneal astigmatism magnitude (diopters) from baseline
Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively
Secondary Outcomes (6)
Visual Acuity-UCVA
Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively
Visual acuity-BCVA
Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively
Manifest refraction spherical equivalent (MRSE) in Diopter (D)
Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively
Corneal Topography
Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively
Objective Optical Quality
Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively
- +1 more secondary outcomes
Study Arms (1)
FSAK with Cataract Surgery
Participants in this group undergo femtosecond laser-assisted arcuate keratotomy (FSAK) combined with standard cataract surgery
Interventions
1. 5-year follow-up assessing stability of astigmatism correction. Most FSAK studies track ≤2 years. This addresses critical evidence gaps in durability 2. Combines topographic data with patient-reported visual function (VF-14/QoV questionnaires at all visits. Links anatomical changes to real-world visual experiences
Eligibility Criteria
Patients with regular corneal astigmatism of 0.75-2.0 D who plan to undergo cataract surgery. Aged between 20 and 80 years old.
You may qualify if:
- Age: 20-80 years
- Age-related cataracts
- Regular corneal astigmatism (0.75-2.0 diopters) confirmed by Pentacam/IOLMaster 700
- Surgical Plan: Scheduled for femtosecond laser-assisted cataract surgery
- Central corneal thickness ≥500 µm
- Endothelial cell count ≥2,000 cells/mm²
- Best-corrected visual acuity (BCVA) improvable to ≥20/40
You may not qualify if:
- Prior corneal refractive surgery (e.g., LASIK, PRK)
- Intraocular surgery (e.g., glaucoma filtering surgery)
- Irregular astigmatism (keratoconus, scarring, post-traumatic distortion)
- Active ocular inflammation or infection
- Corneal endothelial disease (e.g., Fuchs' dystrophy)
- Severe dry eye (Schirmer test ≤5 mm/5 min)
- Uncontrolled glaucoma (IOP \>21 mmHg on medication)
- Macular pathology (e.g., AMD, DME affecting visual potential)
- Amblyopia
- Autoimmune diseases affecting cornea (e.g., rheumatoid arthritis, Sjögren syndrome)
- Diabetes mellitus with retinopathy
- Pregnancy/Lactation
- Inability to complete 5-year follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eye and Ear, Nose, and Throat Hospital of Fudan University
Shanghai, Shanghai Municipality, 200031, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
June 1, 2025
First Posted
July 23, 2025
Study Start
April 22, 2025
Primary Completion (Estimated)
April 22, 2030
Study Completion (Estimated)
April 22, 2031
Last Updated
July 23, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Data contain sensitive biometric identifiers (e.g., corneal topography maps) that cannot be fully de-identified